Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study. // Digestive and Liver Disease. – URL: https://www.sciencedirect.com/science/article/pii/S1590865826009825?dgcid=rss_sd_all
Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study. Digestive and Liver Disease. https://www.sciencedirect.com/science/article/pii/S1590865826009825?dgcid=rss_sd_all
“Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study.” Digestive and Liver Disease.
@article{article89001,
title = {Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study},
journal = {Digestive and Liver Disease},
url = {https://www.sciencedirect.com/science/article/pii/S1590865826009825?dgcid=rss_sd_all}
}